AN ECONOMIC ANALYSIS OF ENDOVASCULAR ARTERIOVENOUS FISTULAS IN DIALYSIS PATIENTS: A US PAYER AND PROVIDER PERSPECTIVE

被引：0
|
作者：
Barclay, B. [1 ]
Druchok, C. [2 ]
Ferko, N. [2 ]
Chen, D. [1 ]
机构：
[1] CR Bard Inc, Tempe, AZ USA
[2] Cornerstone Res Grp Inc, Burlington, ON, Canada
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV27
引用
收藏
页码：S546 / S546
页数：1
相关论文
共 50 条
  • [31] Endovascular Treatment of Noncavernous Dural Arteriovenous Fistulas: Analysis of Outcomes with and without Ethylene Vinyl Alcohol
    Griauzde, Julius
    Gemmete, Joseph J.
    Pandey, Aditya S.
    Chaudhary, Neeraj
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (06): : 1209 - 1215
  • [32] The Economic Impact of Total Knee Replacement in Patients with Haemophilia and Inhibitors: Analysis from a UK Payer Perspective
    Giangrande, P. L. F.
    Solimeno, L. P.
    Santagostino, E.
    Anger, D.
    Rosu, G. N.
    Wilkinson, L.
    HAEMOPHILIA, 2016, 22 : 75 - 76
  • [33] USEFULNESS OF BACK-UP ARTERIOVENOUS FISTULAS (AVF) IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
    Chang, Sean Haw
    Chong, Yok Cheng
    Roslena, M.
    Tan, Si Yen
    NEPHROLOGY, 2005, 10 : A61 - A61
  • [34] Comparison of the efficacy of drug-coated balloon angioplasty and conventional balloon angioplasty in the endovascular treatment of thrombosed arteriovenous dialysis fistulas
    Ozdemir, Mustafa
    Taydas, Onur
    THERAPEUTIC APHERESIS AND DIALYSIS, 2025, 29 (01) : 70 - 78
  • [35] Cost-utility analysis of duloxetine in osteoarthritis: A US private payer perspective
    Wielage R.C.
    Bansal M.
    Andrews J.S.
    Klein R.W.
    Happich M.
    Applied Health Economics and Health Policy, 2013, 11 (3) : 219 - 236
  • [36] Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: US Payer Perspective
    Oh, Mok
    Patanwala, Asad E.
    Alkhatib, Nimer
    Almutairi, Abdulaali
    Abraham, Ivo
    Erstad, Brian
    CRITICAL CARE MEDICINE, 2020, 48 (10) : E906 - E911
  • [37] The cost of care for patients with HIV from the provider economic perspective
    Roberts, Rebecca R.
    Kampe, Linda M.
    Hammerman, Martha
    Scott, R. Douglas, II
    Soto, Tomas
    Ciavarella, Ginevra G.
    Rydman, Robert J.
    Gorosh, Kathye
    Weinstein, Robert A.
    AIDS PATIENT CARE AND STDS, 2006, 20 (12) : 876 - 886
  • [38] ECONOMIC IMPACT OF BALLOON GUIDE CATHETER USE WITH MECHANICAL THROMBECTOMY FOR ACUTE ISCHEMIC STROKE: A US PAYER PERSPECTIVE COST ANALYSIS
    Kottenmeier, E.
    Pederson, J.
    Khaled, A.
    Kabiri, M.
    Brinjikji, W.
    VALUE IN HEALTH, 2022, 25 (07) : S359 - S359
  • [39] Neurosurgical versus endovascular treatment of craniocervical junction arteriovenous fistulas: a multicenter cohort study of 97 patients
    Takai, Keisuke
    Endo, Toshiki
    Seki, Toshitaka
    Inoue, Tomoo
    Koyanagi, Izumi
    Mitsuhara, Takafumi
    JOURNAL OF NEUROSURGERY, 2022, 137 (08) : 373 - 380
  • [40] Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Dialysis Patients: A Canadian Payer Perspective
    Vegter, Stefan
    Tolley, Keith
    Keith, Michael S.
    Lok, Charmaine E.
    Soroka, Steven D.
    Morton, A. Ross
    CLINICAL THERAPEUTICS, 2012, 34 (07) : 1531 - 1543
12345